Phase I Study of Intratumoral CV8102

Conditions:   Melanoma (Skin);   Squamous Cell Carcinoma of the Skin;   Carcinoma, Squamous Cell of Head and Neck;   Carcinoma, Adenoid Cystic
Interventions:   Biological: CV8102;   Biological: CV8102 + anti-PD-1 therapy
Sponsor:   CureVac AG
Not yet recruiting - verified September 2017

http://ift.tt/2xqBOzF